Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

The trial evaluating palifermin for reducing oral mucositis in locally advanced head and neck cancer patients receiving postoperative radiotherapy has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: WITHDRAWN